ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Pressure Grows On Upton To Reveal Plans

November 23, 1979

Healy Transfers $15 Million From NCI to Fund Cancer Research Around NIH; Another $16M Held

January 24, 1992

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986

In Brief: Kripke, Fidler To Leave FCRF for M.D. Anderson; George Todaro Takes Job With New Seattle Firm

March 4, 1983

KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.

December 1, 2000

Moffitt Ends Pilot Study Based On Duke Test, Says Action Unrelated

October 23, 2009